AGEN
Agenus Inc.
Halal Rating :
See Details
Last Price
$10.47
Last updated:
Market Cap
$267.27m
7D Change
-19.89%
1 Year Change
-62.61%
Company Overview
Industries
Exchange
NASDAQ
Next Earnings Date
March 14, 2024
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company is headquartered in Lexington, Massachusetts.
Use of Interest
Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
---|---|---|---|---|---|---|
March 31, 2024 | $28.0m | $93.74m | - | $29.47m | 0.00% | 31.44% |
Dec. 31, 2023 | $83.7m | $136.48m | - | $44.57m | 0.00% | 32.66% |
Sept. 30, 2023 | $24.31m | $89.29m | - | $18.63m | 0.00% | 20.87% |
Company Impact
Help us evaluate Agenus Inc.'s impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.